{
    "eid": "2-s2.0-85167465706",
    "title": "Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "cellular immune response",
        "COVID-19",
        "Elispot",
        "flow cytometry",
        "interferon-\u03b3",
        "kidney transplantation",
        "SARS-CoV-2 vaccine",
        "T cells"
    ],
    "authors": [
        "Suwasin Udomkarnjananun",
        "Sivaporn Gatechompol",
        "Asada Leelahavanichkul",
        "Stephen J. Kerr"
    ],
    "citedby-count": 0,
    "ref-count": 78,
    "ref-list": [
        "Is COVID-19 infection more severe in kidney transplant recipients",
        "Mortality risk factors of COVID-19 infection in kidney transplantation recipients: a systematic review and meta-analysis of cohorts and clinical registries",
        "Immunogenicity rates after SARS-CoV-2 vaccination in people with end-stage kidney disease: A systematic review and meta-analysis",
        "Factors associated with COVID-19 vaccine response in transplant recipients: A systematic review and meta-analysis",
        "Immunogenicity and risk factors associated with poor humoral immune response of SARS-CoV-2 vaccines in recipients of solid organ transplant: A systematic review and meta-analysis",
        "The T cell immune response against SARS-CoV-2",
        "Understanding T cell responses to COVID-19 is essential for informing public health strategies",
        "Cellular immunity is critical for assessing COVID-19 vaccine effectiveness in immunocompromised individuals",
        "Covid-19 vaccines - immunity, variants, boosters",
        "Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients",
        "The PRISMA 2020 statement: an updated guideline for reporting systematic reviews",
        "Bias in meta-analysis detected by a simple, graphical test",
        "Immune responses to SARS-CoV-2 infection and vaccination in dialysis patients and kidney transplant recipients",
        "Immune response to third and fourth COVID-19 vaccination in hemodialysis patients and kidney transplant recipients",
        "Dynamics of humoral and cellular responses in renal transplant recipients receiving 3 doses of SARS-CoV-2 mRNA vaccine",
        "Antibody and T cell response to SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients",
        "Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients",
        "Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients",
        "Six-month follow-up after vaccination with BNT162b2: SARS-CoV-2 antigen-specific cellular and humoral immune responses in hemodialysis patients and kidney transplant recipients",
        "Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients",
        "Effect of a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine on humoral and cellular responses and serum anti-HLA antibodies in kidney transplant recipients",
        "Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine",
        "Poor anti-SARS-CoV-2 humoral and T-cell responses after 2 injections of mRNA vaccine in kidney transplant recipients treated with belatacept",
        "Immunogenicity and safety of two-dose SARS-CoV-2 vaccination via different platforms in kidney transplantation recipients",
        "Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring",
        "Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients",
        "Humoral and cellular immune responses after a 3-dose course of mRNA-1273 COVID-19 vaccine in kidney transplant recipients: A prospective cohort study",
        "T-cell and antibody response after 2 doses of the BNT162b2 vaccine in a belgian cohort of kidney transplant recipients",
        "Discordance between SARS-CoV-2-specific cell-mediated and antibody responses elicited by mRNA-1273 vaccine in kidney and liver transplant recipients",
        "Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients",
        "Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients",
        "SARS-CoV-2 spike-specific IFN-\u03b3 T-cell response after COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant",
        "Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial",
        "Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients",
        "Humoral and T-cell response to SARS-CoV-2 mRNA BNT162b2 vaccination in a cohort of kidney transplant recipients and their cohabitant living kidney donor partners",
        "Determinants of immune response to anti-SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A prospective cohort study",
        "mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients",
        "Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination",
        "Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients",
        "Local and systemic immunity are impaired in end-stage-renal-disease patients treated with hemodialysis, peritoneal dialysis and kidney transplant recipients immunized with BNT162b2 Pfizer-BioNTech SARS-CoV-2 vaccine",
        "Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients",
        "Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients: A randomized clinical trial",
        "Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic",
        "Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection",
        "The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant",
        "Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant",
        "Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients",
        "SARS-CoV2 mRNA vaccine-specific B-, T- and humoral responses in adolescents after kidney transplantation",
        "Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients",
        "Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients",
        "B and T cell responses after a third dose of SARS-CoV-2 vaccine in kidney transplant recipients",
        "Anti-SARS-CoV-2 revaccination success in kidney transplant recipients with no initial humoral response is linked to primary vaccine type",
        "Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine",
        "MMF/MPA is the main mediator of a delayed humoral response with reduced antibody decline in kidney transplant recipients after SARS-CoV-2 mRNA vaccination",
        "Cellular and humoral immune responses after 3 doses of BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant",
        "Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients",
        "Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximab",
        "Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients",
        "Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients",
        "Factors associated with vaccine-induced T-cell immune responses against severe acute respiratory syndrome Coronavirus 2 in kidney transplant recipients",
        "Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers",
        "A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse",
        "Immune response to third dose BNT162b2 COVID-19 vaccine among kidney transplant recipients-A prospective study",
        "Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients",
        "Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipients",
        "The case of the misleading funnel plot",
        "Donor-specific ELISPOT assay for predicting acute rejection and allograft function after kidney transplantation: A systematic review and meta-analysis",
        "A systematic review and meta-analysis of enzyme-linked immunosorbent spot (ELISPOT) assay for BK polyomavirus immune response monitoring after kidney transplantation",
        "Diagnostic performance of cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in kidney transplantation: A PRISMA-compliant article",
        "Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19",
        "Targeting TNF-\u03b1 for COVID-19: recent advanced and controversies",
        "The first asian kidney transplantation prediction models for long-term patient and allograft survival",
        "Impaired immune response to SARS-CoV-2 vaccination in dialysis patients and in kidney transplant recipients",
        "Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis",
        "Maximizing anti-HBs seroresponsiveness in kidney transplant waitlist patients: A tertiary-center perspective",
        "Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology",
        "Effects of glucocorticoids in the immune system"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kensington",
            "@id": "60026655",
            "affilname": "The Kirby Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}